Adviezen bij aften

Huisarts en Wetenschap

Volumn 40, Issue 8, 1997, Pages 389-395

  Wielink, Gert ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMLEXANOX; BENZOIC ACID; BETAMETHASONE; CHLORHEXIDINE; CORTICOSTEROID; FLUOCINONIDE; HEXETIDINE; LEVAMISOLE; LIDOCAINE; MESALAZINE; PROSTAGLANDIN E2; SILVER NITRATE; SUCRALFATE; THALIDOMIDE; TOOTHPASTE; TRIAMCINOLONE;

APHTHOUS STOMATITIS; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LITERATURE; MORBIDITY; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; SHORT SURVEY; TOPICAL DRUG ADMINISTRATION;

EID: 0030845123     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Janssen ALM. Ziekten in de huisartspraktijk. Bunge, Utrecht, 1990.
2. Axell T, Hendricsson V. The occurence of recurrent aphthous ulcers in an adult Swedish population. Acta Odentol Scand 1985: 43: 121-5.
3. Greenberg MS, Ulcerative, vesicular and bullous lesions. In: Lynch MD, editor. Brket's oral medicine. 8th ed. Philadelphia: Lippincott, 1984. p. 181-7.
4. Fahmy MS. Recurrent aphthous ulcers in a mixed Arab community. Commun Dent Oral Epidemiol 1976; 4: 160-4.
5. Embil JA, Stephens RG, Mauriel R. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975; 113: 627-30.
6. Ship II, et al. Recurrent aphthous ulcerations and recurrent herpes labialis in a professional school students population. Oral Surg 1960; 13: 1191-201.
7. Donatsky O. Epidemilogic study on recurrent aphtous ulcerations among 512 Danish dental students. Commun Dent Oral Epidemiol 1973; 1: 37-40.
8. Streefkerk JG, Verheij ThJM. Kleine kwalen in de huisartspraktijk. Utrecht: Bunge, 1993.
9. Van Es RJJ, Van Damme PhA. Met antimicrobieel mondspoelmiddel Listerine Antiseptic minder last van aften? [referaat]. Ned Tijdschr Geneeskd 1992; 136: 1077-8.
10. Limpens MAH. Stomatitis aphtosa: zijn corticosteroïden zinvol? Patient Care 1995: 9-12.
11. Van Damme Ph. Wat zijn oorzaken van aften? Zijn er goede therapiën? Vademecum 1995; 13(45).
12. Boering G, Nijman JH. Mondheelkunde in de algemene praktijk. Alphen aan den Rijn: Stafleu, 1984.
13. Van Everdingen JJE. Dermatovenerologie voor de eerste lijn. Alphen aan den Rijn: Samsom Stafleu, 1990. p. 193-4.
14. Savage NW. Oral ulceration. Assessement of treatment of commonly encountered oral ulcerative disaese. Austr Fam Physicican 1988; 17: 247-50.
15. Ship II. Inheritance of aphthous ulcers of the mouth. J Dent Research 1965; 44: 837-44.
16. Ship II. Epidemiologic aspects of recurrent aphthous ulcerations. Oral Surg Oral Med Oral Path 1972; 33: 400-6.
17. Miller MF, Ship II, Ram C. Inheritance patterns in recurrent aphthous ulcers. Oral Surg Oral Med Oral Path 1977; 43: 886-91.
18. Nolan A, Lamey PJ, Milligan KA, Forsyth A. Recurrent aphthous ulceration and food sensitivity. J Oral Pathol Med 1991; 20: 473-5.
19. Hunter IP, Ferguson MM, Scully C, et al. Effects of dietary gluten elimination in patient with recurrent minor aphthous stomatitis and no detectable gluten enteropathy. Oral Surg Oral Med Oral Path 1993; 75: 595-8.
20. Ratzow F. Kamille, Tabak und Obst als Infektionsträger für die Mundschleimhaut. Quintessenz 1968; 19: 27-8.
21. Ratzow F. Camillo, tobacoo and fruit as infective agent carriers for the oarl mucosa. Quintessenz Int 1970; 1: 27-8.
22. Wegener K. Fruchtsäuren als Ursache der Aphthenbildung? Quintessenz 1972; 23: 18.
23. Eversole LR, Shopper TP, Chambers DW. Effects of suspected foodstuff challenging agents in the etiology of recurrent aphthous stomatitis. Oral Surg Oral Path Oral Med 1982; 54: 33-8.
24. Pedersen A. Psychologic stress and recurrent aphthous ulcerations. J Oral Pathol Med 1989; 18(2): 119-22.
25. McCartan BE, Sullivan A. The association of menstrual cycle, pregnancy and menopause with recurrent aphthous stomatitis: a review and critique. Obstet Gynecol 1992; 80: 455-8.
26. Seedat YK. Aphthous ulcers of mouth from Captopril [letter]. Lancet 1979; 1297-8.
27. Nicholls MG, Maslowski AH, Ikram H, Espiner EA. Ulceration of the tongue: a complication of Captopril therapy. Ann Intern Med 1981; 94: 659.
28. Rennie JS, Reade PC, Hay KD, Scully C. Recurrent aphthous stomatitis [review]. Br Dent J 1985; 159: 361-7.
29. Van der Waal I. Wat te doen bij aften? Ned Tijdsch Tandheelkd 1992; 99: 12.
30. Grady D, Ernster VL, Stillman L, Greenspan J. Smokeless tobacco use prevents aphthous stomatitis. Oral Surg Oral Med Oral Path 1992; 74: 463-5.
31. Brookman R. Relief of canker sores on resumption of cigarette smoking. California Med 1960; 93: 235-6.
32. Dorsey C. More observations on relief of aphthous stomatitis on resumption of cigarette, smoking. California Med 1964; 101: 377-8.
33. Shapiro S, Olsson DL, Chellemsi SJ. The association between smoking and aphthous ulcers. Oral Surg 1970; 30: 624-30.
34. Axell T, Hendriccson V. Association between recurrent aphthous ulcers and tobacco habits. Dent Research 1985; 93: 239-42.
35. Rosmalen CFH, Thomas S, Van der Laan van der JR, et al. Farmacotherapie voor de huisarts, achtergronden. Utrecht: Nederlands Huisartsen Genootschap, 1996.
36. Yeoman CM, Greenspan JS, Harding SM. Recurrent oral ulceration; A double blind comparison of treatment with, betamethasone valerate aerosol and placebo. Br Dent J 1978; 144: 114-6.
37. Pimlott SJ, Walker DM. A controlled clinical trial of the efficiacy of topically applied fluocinonide. in the treatment of recurrent aphthous ulceration. Br Dent J 1983; 154: 174-7.
38. Vincent SD, Lilly GE. Clinical, historic and therapeutic features of aphthous stomatitis; Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Path 1992; 74: 79-86.
39. Miles DA, Bricker SL, Razmus TF, Potter RH. Triamcinolone acetonide versus chlorhexidine for treatment of recurrent stomatitis. Oral Surg Oral Med Oral Path 1993; 75: 397-402.
40. Browne RM, Fox EC, Anderson RJ. Topical triamcinolone acetonide in recurrent aphthous stomatitis. Lancet 1968; 565-7.
41. Lammers W, Nelemans FA, Bouwman ThJ, et al. Algemene farmacologie. Leiden: Stafleu, 1975.
42. Reynolds JEF, Prasad AB. Martindale, the extra pharmacopoeia. London: Pharmaceutical Press, 1982.
43. Meiller TF, Kutcher MJ, Overholser DC, et al. Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations. Oral Surg Oral Med Oral Path 1991; 72: 425-9.
44. Anoniem. Zendium and aphthae [intern rapport/overzicht]. Veenendaal: Kortman Intradal, z.j.
45. Anoniem. Het effekt van tandpasta met enzymen op aphten, verslag van een onderzoek onder aphtenpatiënten van 260 huisartsenpraktijken. Veenendaal: Kortman Intradal, 1987.
46. Tetau M. Materia medica van de homeopathie, kliniek en biotherapie. Parijs: Editions Similia, z.j.
47. Mezger J. Gesichtete Homöopathische Arzneimittellehre. Heidelberg: Karl F. Haug Verlag, z.j.
48. Keller K, Greiner S, Stockebrand P. Homöopatische Arzneimittel. Z.p.: Govi Verlag, 1995.
49. Leeser O. Lehrbuch der Homöopathie. Heidelberg: Karl F. Haug Verlag, z.j.
50. Voisin H. Materia medica der Homöopathischen Praktikers. Heidelberg: Karl F. Haug Verlag, z.j.
51. Asher V. Severe idiopathic recurrent aphthous Stomatitis: treatment with pentoxifylline [letter]. Acta Derm Venereol 1995: 75.
52. Danhof G, Hesselink J, Oudhof HAJ. Laser-therapie in de tandheelkundige praktijk, aphten. Hoogezand, 1992. p. 131-3.
53. Neiburger EJ. The effect of low-power lasers on intra-oral wound healing. New York State Dental Journal 1995; 61: 40-3.
54. Mikhailova RI, Terekhova NV, Zemskaia EA, et al. The laser therapy and laser acupuncture of patients with chronic recurrent. Aphthous stomatitis. Stomatologiia (Mosk) 1992: 27-8.
55. Taylor LJ, Walker DM, Bagg J. A clinical trial of prostaglandin E2 in recurrent aphthous ulceration. Br Dent J 1993; 175: 125-9.
56. Greer jr RO, Lindermuth JE, Juarez T, Khandwala A. A double blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993; 51: 243-8.
57. Collier PM, Neill SM, Copeman PWM. Topical 5-aminosalicylic acid; a treatment for aphthous ulcers. Br J Dermatol 1992; 126: 185-8.
58. Chadwick B, Addy M, Walker DM. Hexetidine mouthrinse in the management of minor apthous ulcerations, and as an adjunct to oral hygiene. Br Dent J 1991; 171: 83-7.
59. Jasmin JR, Muller M, Jonesco N. Local treatment of minor aphthous ulcerations in children. J Dent Children 1993: 26-8.
60. Rattan J, Schneider M, Arber N, et al. Sucralfate suspension as a treatment of recurrent aphthous stomatitis. J Intern Med 1994; 236: 341-3.
61. Walker DM, Dolby AE. Aphthous ulceration, cromoglycic acid and cellular immune respons. Lancet 1975; 1390.
62. Frost M. Cromoglycate in aphthous stomatitis. Lancet 1973; 389.
63. Lu S. Aphthous stomatitis. Int J Clin Acupunct 1994; 5: 439-44.
64. Lehner T, Wilton JMA, Ivanyi I. Double blind cross over trail of levamisole in recurrent aphthous ulceration. Lancet 1976; 926-9.
65. Porter S, Flint S, Scully C. Recurrent aphthous stomatitis: the efficacy of replacement therapy in patients with underlying hematinic deficiencies. Ann Dentistry 1992; 51: 14-6.
66. Woo S-B, Sonis ST. Recurrent aphthous ulcers. A review of diagnosis and treatment. J Am Dent Assoc 1996; 127: 1202-13.
67. Greenspan D, Hilton JF, Westenhouse JL, et al. Association between oral lesions and smoking in a clinical population. Int Conference Aids 1992; 8(2): B147.
68. Grinspan D, Bianco GF, Aguero S. Treatment of aphthae with thalidomide. J Am Acad Dermatol 1989; 20: 1060-3.
69. Grosshans E, Illy G. Thalidomide therapy for inflammatory dermatoses. Int J Dermatol 1984; 23: 598-602.
70. Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990; 126: 923-7.
71. Patterson DL, Georghiou PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995; 20: 250-4.
72. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human, immunodeficiency virus infection. N Engl J Med; 1997: 336: 1487-93.
73. Williams I, Weller IVD, Malin A, et al. Thalidomide hypersensitivity in aids. Lancet 1991; 237: 436-7.